Preferred Stock and Convertible Preferred Stock	6 Months Ended
Jun. 30, 2024
Equity [Abstract]
Preferred Stock and Convertible Preferred Stock	11. Preferred Stock and Convertible Preferred Stock Preferred stock As of June 30, 2024 and December 31, 2023, the Company was authorized to issue up to 10,000,000 shares of preferred stock at a par value of $0.001. As of June 30, 2024 and December 31, 2023, no shares of preferred stock were issued and outstanding. Convertible preferred stock On February 23, 2023, Former Enliven completed the Merger with the Company in accordance with the Merger Agreement. Under the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each share of Former Enliven’s convertible preferred stock was converted into a share of Former Enliven’s common stock. At closing of the merger, the Company issued an aggregate of 34,426,351 shares of its common stock to Former Enliven stockholders, based on an exchange ratio of approximately 0.2951 shares of the Company’s common stock for each share of Former Enliven’s common stock outstanding immediately prior to the Merger, including those shares of common stock issued upon conversion of Former Enliven's convertible preferred stock.

Preferred Stock and Convertible Preferred Stock

6 Months Ended

Jun. 30, 2024

Preferred Stock and Convertible Preferred Stock

11. Preferred Stock and Convertible Preferred Stock

Preferred stock

As of June 30, 2024 and December 31, 2023, the Company was authorized to issue up to 10,000,000 shares of preferred stock at a par value of $0.001. As of June 30, 2024 and December 31, 2023, no shares of preferred stock were issued and outstanding.

Convertible preferred stock

On February 23, 2023, Former Enliven completed the Merger with the Company in accordance with the Merger Agreement. Under the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each share of Former Enliven’s convertible preferred stock was converted into a share of Former Enliven’s common stock. At closing of the merger, the Company issued an aggregate of 34,426,351 shares of its common stock to Former Enliven stockholders, based on an exchange ratio of approximately 0.2951 shares of the Company’s common stock for each share of Former Enliven’s common stock outstanding immediately prior to the Merger, including those shares of common stock issued upon conversion of Former Enliven's convertible preferred stock.